A.M. Vitals: More Light Shed on J&J, FDA Communication


Published On: September 21st, 2010

In the Loop: J&J says it kept the FDA informed of its plan to quietly remove defective Motrin from the shelves rather than carry out a recall, according to correspondence between the company and an FDA official, the WSJ reports. However, the FDA says it wasn’t aware of the efforts.

The company faces a second congressional hearing at the end of the month  where lawmakers plan to ask in greater detail about the issue. FDA deputy commissioner Joshua Sharfstein has been invited to testify about the communication …

Originally posted here: 
A.M. Vitals: More Light Shed on J&J, FDA Communication

STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

Stop Panic Attacks
The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.

try-now

YouTube Video



Loading...


Did You Know Did you know:


Colorectal: 47.4 per 100,000 people per year

Related Posts

  • A.M. Vitals: More J&J Products Scrutinized By Congress
    Also: Mass. ..
  • A.M. Vitals: More Disclosure from J&J
    Letting in More Light: Johnson & Johnson is disclosing more payments it makes to physicians, reports the WSJ . Building on its  pledge to make public how much it pays docs who work with its pharmaceutical subsidiaries, which can now be found on their websites, the health-products maker will include reporting from its medical-device and..
  • A.M. Vitals: J&J Subject to Five Years of FDA Oversight
    Mutual Consent: Johnson & Johnson’s McNeil Consumer Healthcare unit faces at least five years of regulatory oversight under the terms of a consent decree that doesn’t fine the company or close down additional plants, the WSJ reports . The decree, prompted by manufacturing problems that have resulted in a series of recalls , requires J&J..
  • A.M. Vitals: Vertex, J&J Hepatitis C Drug Wins FDA Approval
    Hep C Drugs: Incivek, the hepatitis C drug from Vertex Pharmaceuticals and Johnson & Johnson, won FDA approval, setting up a marketing battle with Merck’s new drug Victrelis, which was approved a week ago, the WSJ reports . Both drugs are added to existing therapies and will be expensive; a course of Victrelis will cost..
  • FDA Identifies More Problems at J&J Plant
    A J&J spokesman says the company will “quickly provide a detailed response to the FDA and work to address these most recent observations.” ..
  • A.M. Vitals: J&J Documents Raise Questions About 2009 Recall
    Also: most Americans now probably immune to 2009 H1N1 strain; federally funded embryonic stem cell research can continue — for now. ..
Leave a comment
Comments are closed.
« Big Prize for Leptin, Age-Related Blindness Scientists Report: Global Alzheimer’s Costs to Top $600 Billion »